Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca celebrates latest successful trial of acoramidis in Japan

2nd Feb 2024 08:38

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan. Read More

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

2nd Feb 2024 06:22

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines. Read More

UK earnings, trading statements calendar - next 7 days

1st Feb 2024 15:52

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

29th Jan 2024 08:19

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours. Read More

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

19th Jan 2024 09:28

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH. Read More

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

16th Jan 2024 11:58

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates. Read More

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

GSK bolsters respiratory pipeline with USD1.4 billion acquisition

9th Jan 2024 11:51

(Alliance News) - GSK PLC's latest acquisition of Aiolos Bio Inc reflects its focus on respiratory diseases, with the latter's key asset potentially offering a chance to differentiate from rivals, Third Bridge noted. Read More

Berenberg hails AstraZeneca's Alexion as "high-value asset"

9th Jan 2024 11:43

(Alliance News) - German bank Berenberg talked up AstraZeneca PLC's Alexion Pharmaceuticals, believing it is still in good shape despite some competitors entering the market. Read More

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

3rd Jan 2024 16:52

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes. Read More

IN BRIEF: Nuformix narrows annual loss as develops drug assets

3rd Jan 2024 10:16

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses. Read More

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

3rd Jan 2024 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

3rd Jan 2024 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

3rd Jan 2024 08:58

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively. Read More

C4X receives USD11 million from AstraZeneca following NRF2 trials

3rd Jan 2024 08:04

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment. Read More

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

3rd Jan 2024 07:54

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York. Read More

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

2nd Jan 2024 12:01

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December. Read More

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

2nd Jan 2024 08:48

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due. Read More

AstraZeneca and Sanofi received approval in China for RSV antibody

2nd Jan 2024 08:26

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday. Read More

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

2nd Jan 2024 07:57

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK. Read More

FTSE 100 Latest

Value9,527.65

Change20.24